36 studies found for:    Open Studies | "Kidney Diseases, Cystic"
Show Display Options
Rank Status Study
1 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
2 Recruiting Contrast-enhanced Ultrasound for the Evaluation of Complex Renal Cysts
Condition: Complex Renal Cyst
Intervention: Procedure: Contrast-enhanced ultrasound
3 Recruiting Clinical and Molecular Investigations Into Ciliopathies
Conditions: Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
Intervention:
4 Recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
5 Recruiting Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
6 Recruiting Transplant Patient Registry of Liver, Kidney and/or Pancreas
Conditions: Hepatitis B;   Hepatitis C;   Liver Cirrhosis;   Hepatocellular Carcinoma;   Polycystic Kidney Diseases
Intervention:
7 Unknown  Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
Condition: Kidney, Polycystic, Autosomal Dominant
Interventions: Drug: Cilnidipine;   Drug: Imidapril
8 Recruiting Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease
Conditions: Polycystic Kidney, Type 1 Autosomal Dominant Disease;   Polycystic Kidney, Type 2 Autosomal Dominant Disease
Interventions: Drug: Sirolimus;   Drug: Placebo
9 Recruiting Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells
10 Recruiting Sirolimus for Massive Polycystic Liver
Condition: Polycystic Kidney Diseases
Intervention: Drug: Sirolimus
11 Recruiting Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Hypertension
Interventions: Procedure: renal sympathetic denervation;   Drug: antihypertensive drugs
12 Recruiting The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
13 Not yet recruiting The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Everolimus;   Drug: Calcineurin inhibitors maintenance
14 Not yet recruiting New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Kidney Disease
Intervention:
15 Recruiting PKD Clinical and Translational Core Study
Condition: Polycystic Kidney Disease
Intervention:
16 Recruiting Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
Condition: Kidney, Polycystic, Autosomal Dominant
Intervention: Procedure: video thorascopic splanchnicectomy (VSPL)
17 Recruiting Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease
Condition: Adult Polycystic Kidney Disease
Intervention: Procedure: renal denervation
18 Recruiting A Safety, Pharmacokinetic and Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Polycystic Kidney, Autosomal Dominant
Intervention: Drug: KD019
19 Recruiting Study of Lanreotide to Treat Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention: Drug: Lanreotide
20 Recruiting Pasireotide LAR in Severe Polycystic Liver Disease
Conditions: Somatostatin Analogs;   Polycystic Liver Disease;   Autosomal Dominant Polycystic Kidney Disease;   Autosomal Dominant Polycystic Liver Disease
Interventions: Drug: Pasireotide LAR;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results
Indicates status has not been verified in more than two years